Adherium (ASX:ADR) said it has received firm commitments for AU$2.6 million convertible notes to support the roll-out of its proprietary Hailie Smartinhaler platform in the US, according to a Tuesday Australian bourse filing.
The capital raise is expected to issue 2.6 million convertible notes maturing in nine months at an interest of 10% per year. Participants will also receive one attached option per two shares subscribed.
PAC Partners and Stralis Capital were the joint lead managers for the capital raise.
The company reaffirmed its guidance to onboard another 1,800 active patients during the next six months and 9,000 active patients by the end of the year.
Its shares rose 10% on market close.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。